Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE42.3000
- TODAY'S CHANGE (%)0.3300 (0.7863%)
- Bid / Lots42.2900/ 2
- Ask / Lots42.3200/ 1
- Open / Previous Close41.8700 / 41.9700
- Day Range
- 52 Week Range
- Volume193,306
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 6616 | 41.9 |
| 09:34 ET | 3699 | 41.8 |
| 09:38 ET | 3553 | 41.8 |
| 09:39 ET | 1720 | 41.76 |
| 09:41 ET | 1227 | 41.8 |
| 09:43 ET | 921 | 41.96 |
| 09:45 ET | 100 | 41.945 |
| 09:48 ET | 853 | 42.03 |
| 09:50 ET | 100 | 41.96 |
| 09:52 ET | 400 | 41.94 |
| 09:54 ET | 400 | 41.9 |
| 09:56 ET | 900 | 42.01 |
| 09:57 ET | 273 | 42 |
| 09:59 ET | 1400 | 42.04 |
| 10:01 ET | 602 | 42.15 |
| 10:03 ET | 890 | 42.21 |
| 10:06 ET | 1430 | 42.274 |
| 10:08 ET | 1767 | 42.335 |
| 10:10 ET | 1073 | 42.32 |
| 10:12 ET | 650 | 42.37 |
| 10:14 ET | 1334 | 42.46 |
| 10:15 ET | 2360 | 42.45 |
| 10:17 ET | 683 | 42.38 |
| 10:19 ET | 2200 | 42.37 |
| 10:21 ET | 200 | 42.38 |
| 10:24 ET | 700 | 42.33 |
| 10:26 ET | 1650 | 42.32 |
| 10:28 ET | 1512 | 42.31 |
| 10:30 ET | 800 | 42.365 |
| 10:32 ET | 900 | 42.33 |
| 10:33 ET | 300 | 42.31 |
| 10:35 ET | 842 | 42.325 |
| 10:37 ET | 130 | 42.34 |
| 10:39 ET | 400 | 42.29 |
| 10:42 ET | 400 | 42.225 |
| 10:44 ET | 1083 | 42.24 |
| 10:48 ET | 1796 | 42.2 |
| 10:50 ET | 1000 | 42.225 |
| 10:51 ET | 1350 | 42.225 |
| 10:53 ET | 100 | 42.21 |
| 10:55 ET | 700 | 42.22 |
| 10:57 ET | 200 | 42.2 |
| 11:00 ET | 1405 | 42.16 |
| 11:02 ET | 2159 | 42.12 |
| 11:04 ET | 1951 | 42.1548 |
| 11:06 ET | 1100 | 42.165 |
| 11:08 ET | 1000 | 42.13 |
| 11:09 ET | 400 | 42.11 |
| 11:11 ET | 305 | 42.095 |
| 11:13 ET | 600 | 42.105 |
| 11:15 ET | 400 | 42.1 |
| 11:18 ET | 500 | 42.09 |
| 11:20 ET | 2050 | 42.08 |
| 11:22 ET | 400 | 42.06 |
| 11:24 ET | 901 | 42.08 |
| 11:26 ET | 200 | 42.06 |
| 11:27 ET | 2427 | 42.08 |
| 11:29 ET | 1590 | 42.1 |
| 11:31 ET | 1400 | 42.15 |
| 11:33 ET | 1400 | 42.12 |
| 11:36 ET | 620 | 42.13 |
| 11:38 ET | 3787 | 42.08 |
| 11:40 ET | 1592 | 42.0758 |
| 11:42 ET | 845 | 42.11 |
| 11:44 ET | 500 | 42.14 |
| 11:45 ET | 300 | 42.18 |
| 11:47 ET | 1050 | 42.23 |
| 11:49 ET | 1375 | 42.24 |
| 11:51 ET | 1167 | 42.3 |
| 11:54 ET | 300 | 42.3 |
| 11:56 ET | 650 | 42.36 |
| 11:58 ET | 1000 | 42.4 |
| 12:00 ET | 1400 | 42.34 |
| 12:02 ET | 1519 | 42.405 |
| 12:03 ET | 157 | 42.41 |
| 12:05 ET | 2295 | 42.45 |
| 12:07 ET | 1250 | 42.47 |
| 12:09 ET | 1111 | 42.39 |
| 12:12 ET | 824 | 42.39 |
| 12:18 ET | 604 | 42.3709 |
| 12:20 ET | 500 | 42.33 |
| 12:21 ET | 700 | 42.35 |
| 12:23 ET | 200 | 42.36 |
| 12:25 ET | 1400 | 42.3 |
| 12:27 ET | 900 | 42.285 |
| 12:30 ET | 300 | 42.3 |
| 12:32 ET | 100 | 42.28 |
| 12:34 ET | 500 | 42.28 |
| 12:36 ET | 2002 | 42.32 |
| 12:38 ET | 600 | 42.3 |
Apr 25, 2024
Ionis Publishes 2023 Corporate Responsibility Report, from 7:00AM ET on Thursday Apr 25, 2024 by Dow Jones
7:00AM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 23, 2024
Ionis to hold first quarter 2024 financial results webcast, from 7:05AM ET on Tuesday Apr 23, 2024 by Dow Jones
7:05AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 10, 2024
DJ Ionis Pharmaceuticals Raised to Outperform From Peer Perform by Wolfe Research, from 4:42AM ET on Wednesday Apr 10, 2024 by Dow Jones
4:42AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 9, 2024
DJ Ionis Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:38AM ET on Tuesday Apr 09, 2024 by Dow Jones
8:38AM ET on Tuesday Apr 09, 2024 by Dow JonesDJ Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham, from 6:44AM ET on Tuesday Apr 09, 2024 by Dow Jones
6:44AM ET on Tuesday Apr 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 6.1B | -16.5x | --- |
Halozyme Therapeutics Inc | 5.1B | 19.3x | --- |
Apellis Pharmaceuticals Inc | 5.8B | -10.7x | --- |
Intra-Cellular Therapies Inc | 7.3B | -48.2x | --- |
ACADIA Pharmaceuticals Inc | 2.8B | -46.1x | --- |
Blueprint Medicines Corp | 6.7B | -22.2x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Executive Vice President, Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.1B |
|---|---|
Revenue (TTM) | $787.6M |
Shares Outstanding | 145.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.37 |
EPS | $-2.56 |
Book Value | $2.68 |
P/E Ratio | -16.5x |
Price/Sales (TTM) | 7.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
